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Abstract Bony metastases are a fre-
quent problem in elderly patients af-
fected by cancer, and those with bony
metastases involve the spine in ap-
prox. 50%. The most frequent spinal
metastases (60%) are from breast,
lung, or prostate cancer. The chance
that an elderly patient (60–79 years
old) is affected by bony metastases is
four times higher in men and three
times higher in women than a mid-
dle-aged patient (40–59 years old).
Since the medical treatment with all
the adjuvant treatment options pro-
long the survival of this particular
patient group, the spinal metastases
may become a mechanical issue, thus
requesting surgical treatment. Differ-
ent classification systems have been
proposed to rationalize surgical indi-
cations, some concentrating solely
on the local spinal tumor involve-
ment and some including the overall
clinical situation. Since most of the
surgical options are of palliative
character, it is more important to base
the decision on an overall clinical
classification including the different
treatment modalities – irradiation,
chemotherapy, steroids, bisphospho-
nates, and surgery – to make a shared
decision. In case surgery is indicated
– neural compression, pathological
fracture, instability, and progressive
deformity, nursing reasons – the most
straightforward procedures should be
chosen, which may not need an in-
tensive care unit stay. In the thora-
columbar spine a posterior decom-
pression and posterolateral vertebral
body resection through a posterior
approach only, with a concomitant
reconstruction and stabilization, has
shown to work sufficiently well. In
the middle and lower cervical spine
the anterior approach with anterior
decompression and anterior column
reconstruction is most effective and
has a low morbidity, whereas the oc-
cipitocervical junction can generally
be treated by posterior resection and
stabilization. The outcome should be
determined by the survival time in an
ambulatory, independent status, where
pain is controlled, and the patient is
not hospitalized. Surgical manage-
ment shows the greatest improve-
ment in pain reduction, but also in
other domains of quality of life.
Since prospective randomized stud-
ies comparing different treatment
modalities for spinal metastases in-
cluding surgery are not available and
are ethically difficult to achieve,
each case remains an interdiscipli-
nary, shared decision making process
for what is considered best for a pa-
tient or elderly patient. However,
whenever surgery is an option, it
should be planned before irradiation
since surgery after irradiation has a
significant higher complication rate.
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Introduction
Bony metastases are a frequent event in breast, prostate,
lung, kidney urinary bladder, and thyroid cancer as well as
in multiple myeloma and other hematological malignan-
cies which may, however, be considered as primary tu-
mors. About 10% of the cancer patients are attained by
metastases located in the spine [23, 36] (incidence 1999,
SEER and NPCR Registries, United States Cancer Statis-
tics; SEER Cancer Statistics Review 1975–2000, National
Cancer Institute). Among adults 60% of spinal metastases
are either from breast, lung, or prostate cancer. Renal and
gastrointestinal malignancies each account for about 5%
of spinal metastases, and thyroid carcinomas and melanomas
occurring with a lesser frequency [2, 24] (incidence 1999,
SEER and NPCR Registries, United States Cancer Statis-
tics; SEER Cancer Statistics Review 1975–2000, National
Cancer Institute). Since these tumors are increasingly ac-
cessible to treatment by surgery, radiation therapy, and
chemotherapy, thus prolonging the survival of the affected
patients, there is also an increased probability of them be-
ing affected by metastases, i.e., with the improved sur-
vival, previously silent spinal metastases are becoming
clinically apparent and significantly impairing quality of
life. Metastatic disease involving the spine most often af-
fects the vertebral bodies of the thoracic, lumbar, cervical,
and sacral spine. Siegal et al. [46] estimated that approx.
5% of patients with cancer metastases develop cord com-
pression. In patients with spinal metastases approx. 20%
have a cord compression.
Many of the above primary tumors affect persons of ad-
vanced age (60% of cancer patients are older than 65 years;
incidence 1999, SEER and NPCR Registries, United
States Cancer Statistics; SEER Cancer Statistics Review
1975–2000, National Cancer Institute; World Health Or-
ganization report: “Pain in the elderly with cancer,” www.
whocancerpain.wisc.edu), and therefore the metastases
become a major issue in the elderly. The average age of
patients affected by secondary spinal tumors is 55 – 60 years
[23] when considering all metastases; however, it is sig-
nificantly higher when considering tumors that are more
prevalent in the elderly such as prostate cancer and multi-
ple myeloma (Table 1). Prostate cancer, for example, is at
least six times more frequent in men aged 60 – 79 years
than in those 40 – 59 years old. Breast cancer is almost
double and lung cancer five times higher in the elderly (60 –
79 years) than in the middle-aged (40 – 59 years). Al-
though cancer is one of the major causes of morbidity and
mortality, elderly persons are often excluded not only
from clinical cancer studies but also from standard treat-
ment, and generally also from cancer screening because
comorbidity and frailty alter the risk benefit of screening
(World Health Organization report: “Pain in the elderly
with cancer,” www.whocancerpain.wisc.edu). There is
clearly an underrepresentation of older persons in drug
studies, as documented by the United States Food and
Drug Administration (http://cbsnewyork.com, 19 July 2003).
Spinal metastases can become a major burden for el-
derly because it usually affects the quality of life by re-
ducing the endurance, the capacity to ambulate, and the
ability for physical activity. Due to their age these patients
often have other diseases which already limit their quality
of life or have metastases in other skeletal areas, therefore
limiting even more the therapeutic options which may still
be considered in younger patients.
Pathological anatomy and classification
Malignant metastatic cells most frequently spread to the
spine hematogenously with tumor emboli following the
paravertebral plexus (plexus of Batson) [3, 11, 45, 53] that
is characterized by a lack of valves. It is postulated that
the venous blood return is shifted into the paravertebral
plexus via the intervertebral and basivertebral veins due to
increased intra-abdominal and intrathoracic pressure. As a
result metastases which follow this pathway result in the
characteristic pattern of bony spread because tumor cells
are seeded by this mechanism into the capillary network
of the vertebral bodies. Due to its avascular nature the
disc is usually spared from tumor involvement: however,
the most frequently and severely affected part of the ver-
tebra is the vertebral body (in about 80%) followed by the
pedicles and the posterior elements. This constellation ex-
plains why most of the spinal metastasis are located in
front of the spinal cord or dural sac ending up with an an-
terior epidural compression. More than 90% of spinal
metastases are extradural and only 5% intradural and less
than 1% intramedullar [45]. Less frequently cancer cells
spread into the spine through aortic segmental arteries, for
example, in lung cancer [45, 49]. Finally there is also the
option of direct spread through direct tumor infiltration
into the spine, e.g., the Pancoast’s tumor of the lung.
There have been several attempts to classify and stage
spinal tumors [7, 8, 9, 13, 16, 17, 27, 28, 50, 51]. DeWald
et al. [13] suggested a classification system for spinal
metastases that is oriented mainly towards surgical treat-
Table 1 Probability of developing invasive cancer (percentages)
at selected ages with spinal metastasis (from [23])
40–59 years old 60–79 years old
Breast cancer 4.06 (1 in 25) 6.88 (1 in 15)
Prostate cancer 1.90 (1 in 53) 13.69 (1 in 7)
Lung cancer
Male 1.29 (1 in 78) 6.35 (1 in 16)
Female 0.94 (1 in 106) 3.98 (1 in 25)
All sites
Male 8.17 (1 in 12) 33.65 (1 in 3)
Female 9.23 (1 in 11) 22.27 (1 in 4)
ment. They proposed the following five classes with sub-
groups covering most of the possibilities of spinal metas-
tases appearance:
– Class I: destruction without collapse but with pain.
– Class II: the addition of moderate deformity and col-
lapse with immune competence. This class is consid-
ered a good risk for surgery.
– Class III: patients are immunocompromised with mod-
erate deformity and collapse. This class carries greater
risk for surgery.
– Class IV: includes patients with paralysis, collapse, and
deformity with immune competence. This class is con-
sidered a relative surgical emergency.
– Class V:adds immune incompetence to paralysis, col-
lapse, and deformity. This class is not considered a good
operative risk.
This classification allows consideration of the tumor, po-
tential instability, and patient physiology, which is a sen-
sible approach to a difficult problem. Enneking et al. [17]
developed a staging scheme for malignant tumors of the
spine in particular in adaptation to the staging of muscu-
loskeletal tumors in general. The WBB Surgical Staging
System was been introduced in 1997 primarily for pri-
mary bone tumors of the spine [9]. This can be applied for
metastatic spine tumors; however, there are presently few
reports on the system’s correlation with, for example, out-
come when applied for surgical indications. Tokuhashi et
al. [50] introduced a scoring system for the preoperative
evaluation of metastatic spine tumor prognosis that, in-
stead, allows a correlation of the tumor extent with the
prognosis [51]. The system differentiates between intra-
compartmental, extracompartmental, and multiple tumor
involvement. The first two categories include types 1 – 3
and types 4 – 6, respectively, whereas multiple tumor in-
volvement is categorized as type 7 (Fig. 1). This scoring
system found increasing application in recent years as a
baseline in publications to make the results comparable
among different scientific publications. K. Tomita et al.
[51] applied this system to propose their surgical strategy
in spinal metastatic disease.
Clinical presentation and Imaging
The clinical presentation of metastatic spine disease is pre-
dominantly pain, neurological deficit, progressive defor-
mity, and general weakness. Pain may be localized to a
certain structure and region of the spine and may be of
radicular or medullary origin. The pain is either caused by
increased intraosseous pressure in the vertebral bodies
due to cellular invasion of the cancellous bone, by com-
pression of neural structures such as roots or nervous
fibers, by a secondary instability due to the osteoligamen-
tous destruction of parts of the axial skeleton, or by the in-
filtration of the dura or other neuroanatomical structures.
Pain is usually indicated as more or less constant, dull,
however with a predominance of night pain and often not
to be influenced by the regulation of the physical activi-
ties. Generally speaking, slowly progressive, dull neck or
back pain which occurs in a patient with a known cancer
disease or which may become apparent in an elderly pa-
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Fig. 1 Tokuhashi et al. [50]
scoring system to establish pre-
operative prognosis of metasta-
tic spine tumor
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tient without a history of a tumor, should be considered as
caused by a spinal metastases until proven otherwise [20].
The neurological deficit appears clearly with a delay of
weeks to months after the initial presentation of pain. The
period between initial pain and neurological deficit is for
the cervical and thoracic spine weeks to months but in the
lumbar spine days to weeks [1, 31]. The patients may
have motor or sensory deficit or both, whereas there is the
option of pure radicular and/or a medullary compression.
Since most tumors start in the vertebral body, an anterior
cord compression can be expected which is represented
by a deficit of the corticospinal pathways with the clinical
presentation of a spastic paraparesis which may finally re-
sult in an inability to ambulate [20, 46]. Spastic parapare-
sis appears usually before sensory disturbances. It can
progress slowly but always have the potential to deterio-
rate within days.
Many patients who present to the spine surgeon with a
paraparesis reveal a long history of preliminaries for weak-
ness when specifically asked [2]. The loss of the ambula-
tory capacity may arrive quickly. Sensory disturbances
may start with tingling sensation and other dysesthesias
that may, again, fairly quickly convert into a loss of most
the sensory modalities, even within hours. Further com-
pression may lead to a paresis of the bladder and sphinc-
ter and sensory deficits as well as sensory dysfunction in
general may become apparent and finally incapacitate the
patient. Bladder and sphincter dysfunction are usually ir-
reversible if they last more than 48 h or even shorter [12,
13, 18, 25]. Sphincter disturbances also present rather
late, and in elderly persons less attention may be given to
this issue, since men may have preexisting micturation
difficulty with a prostate problem and women with the
bladder/uterus relationship as well as a weak pelvic floor.
Obviously there may be an urine retention present or dif-
ficulty to initiate the micturation as well as a bladder with
an overflow or a weakness, presenting as incontinence.
These clinical presentations are often irreversible and are
nonfavorable prognostic factors.
The cerebrospinal fluid acts as a puffer for a compres-
sive process, and even in case the cord is already com-
pressed it is first a deterioration in the capillary circulation
in the spinal cord which only secondary causes relevant
cord damage [26]. Segmental or even multisegmental in-
stability may be a major pain generator as well as genera-
tor for neurological functional deficit through temporary
or dynamic mechanical compression of neurostructures.
This instability occurs with the destruction of the domi-
nant stabilizing elements of the spine, i.e., the posterior el-
ements such as the facet joints, pedicles, laminae, and
spinous processes including the soft tissue including liga-
ments and joint capsules which all contribute to the stabil-
ity. Since most of the vertebral metastases affect primarily
the vertebral bodies which are the major structure of the
anterior column, metastases do not necessarily coinci-
dence with instability, as long as the vertebral body con-
tours are intact. Only when the bony structure of the ver-
tebral body is weakened by the replacement of bone by tu-
mor tissue (osteolytic metastases) with the result of a
pathological fracture, may the anterior column be weak-
ened sufficiently to make it collapse. Usually the posterior
elements are also involved to some extent at this point and
render the segment definitely unstable. Osteoblastic tumor
metastases are prone to pathological fractures with frag-
ment displacements only if there is a certain mix with os-
teolytic components. Osteoblastic metastases can reach a
considerable hardness which makes a fracture rather im-
probable; however, they can initiate radicular or medullar
compression due to the solidity of the tumor tissue.
In elderly patients who complain of slowly increasing
pain which occurs also during sleeping in the low back re-
gion, gluteal region, groin, knee, or generally in the lower
extremity, may have a hip or knee problem, however, re-
main suspicious for a metastatic bone cancer, specifically
if they have a tumor history or clinical signs of a consum-
ing disorder. Also newly appearing neck pain in an elderly
person should be taken seriously by the first consulted
physician and not just automatically considered as an ex-
pression of a degenerative cervical spine disease.
The advent of magnetic resonance imaging (MRI) has
certainly added a new dimension to the tumor diagnostic
of the spine, although computed tomography (CT), specif-
ically combined with myelography may still have a rele-
vant role to play, since CT may show more precisely the
bony involvement. However, as a search methodology
and for appreciation of the spinal tumor involvement MRI
is the diagnostic tool of choice. It is noninvasive, in con-
trast to myelography, which may even be promoting a
neurological deterioration combined with CT. It cannot be
overlooked, however, that MRI may be overinterpreted by
the examiner, and sometimes in cases in which a precise
preoperative diagnostic work-up is necessary for the sur-
gical planning CT may be more appropriate. The MRI of-
fers a good visualization of the soft tumor involvement. In
T1-weighted images metastatic tumors appear usually in a
hypodense form, whereas in T2-weighted images tumors
of the spine are rather hyperdense as an expression of an
increased water content or replacement of the fatty mar-
row of the bone by tumor cells [26]. Metastases show
gadolinium enhancement. In the tumor work up a bone
scintigraphy may play its role as search tool for skeletal
metastases. A radioisotopic study has a sensitivity of 65–
70%; however, it is preferred to the other studies because
the whole body can be searched. For a more specific
search in an anatomical region, for example, the cervical,
thoracic, or lumbosacral spine the MRI has a higher sen-
sitivity than the bone isotope study [20].
Treatment modalities
Although there is no class I evidence (double-blind ran-
domized placebo-controlled trial) for any of the treatment
modalities indicated in the treatment of spinal metastases,
there are several treatment options recommended. In the
case of neurological deficit dexamethasone is the only
treatment, which has proven evidence of therapeutic effi-
cacy [29, 35, 40, 52]. The therapeutic decision in elderly
frail patients is particularly difficult when they also have
significant comorbity. Nevertheless there are today essen-
tially four modalities of treatment available after the ad-
ministration of steroid: (a) irradiation, (b) surgery, (c) bis-
phosphonates, and (d) rarely chemotherapy and hormonal
therapy as an adjuvant therapy in well defined tumor types
[47]. A fifth possibility is a combination of all the above.
The efficacy of these diverse treatment modalities and the
survival rate of patients depend on the histological tumor
type, tumor stage, therapeutic control of the primary tu-
mor, and tumor spread. Overall survival in this patient cat-
egory is around 12 months [12, 15, 33, 48, 51, 54, 56].
The indications for treatment are given not merely by
the neurocompression but also alsol by the major determi-
nants of quality of life: (a) pain, be it radicular, medullar,
or of dural origin caused by direct or chronic compression
through instability and/or progressive deformity of the
vertebral column, or be merely by intravertebral pressure
elevation due to tumor invasion, (b) loss of mobility, and
(c) nursing reasons. This decision-making process is diffi-
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Fig. 2 Long fixation in progressing deformity and instability a A
62-year-old woman with multiple-level involvement of the cervi-
cal, thoracic, and lumbar spine metastases of a breast cancer with
neurological deficit and pain due to progressing deformity and in-
stability. b Long fixation (sublaminar wiring-metal-cement com-
pound) and partial correction from C1 to the lower thoracic spine
in combination with irradiation was most efficient in reducing pain
and neurological deficit for more than 3 years. c A 58-year-old
man with a hypernephroid carcinoma and cervical involvement
had previous anterior surgery and a cement block posteriorly (as-
terisk) with consecutive progression of the tumor, loosening of the
fixation and a nonunion at the cement-bone interface (arrow).
d Posterior removal of the cement block and stabilization were fol-
lowed by e anterior revision and restabilization after a previous
embolization of the tumor and occlusion of one of the vertebral ar-
teries. The patient died 2 years after this surgery from metastatic
complications other than the cervical spine
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cult since a surgical option is often declined because of the
possible comorbities, which, however, have never been
evaluated in an appropriate controlled study.
Nevertheless it is clinical experience that patients who
had surgery and were not delayed in the postsurgical re-
covery phase due to relevant medical problems and com-
plications belong to the most grateful patients in spinal
surgery although the surgery is purely palliative. This ob-
viously raises the question of whether the surgery can be
simplified and minimized in elderly patients to prevent as
much as possible the adverse effects of surgery [37, 38].
Furthermore there is a still ongoing debate as to whether
patients should be treated with radiation therapy alone or
in combination with decompression, both modalities en-
hanced by the administration of high-dose steroids [14,
18, 58]. The general opinion has long been influenced –
and still is – by a study in the 1980s which showed no sig-
nificant difference between patients who had irradiation
alone or decompression through laminectomy alone [58] with
respect to pain relief, motor performance, and sphincter
function. The combination of radiotherapy and laminec-
tomy did not change the outcome significantly compared
to radiation therapy alone. A major argument today, how-
ever, is that decompression alone in form of a laminec-
tomy without a concomitant stabilization is in most cases
insufficient to affect the pain relevantly; in fact decom-
pression alone may even increase the instability and fur-
ther contribute to pain syndrome and neurological deficit.
Furthermore a laminectomy compared to a vertebrectomy
or at least an anterior decompression cannot achieve the
same degree of decompression since 80% of the tumor
compressions arise anteriorly where it cannot be reached
by laminectomy. The role of the decompression through
laminectomy in spinal metastases has become increas-
ingly debatable with the enhanced experimental biome-
chanical knowledge as well as in vivo studies in monkeys,
where the spinal cord hemodynamics could never be re-
stored after laminectomy alone demonstrating the insuffi-
cient effect of a laminectomy alone [14]. The clinical ex-
perience with the introduction of instrumentation shows
that the realignment of a multiply involved collapsing
spine has significantly improved the neurological deficit
of patients with spinal metastases (Fig. 2) [5, 6, 10, 13, 32,
41, 48, 57].
Today the debated question is whether irradiation alone
is sufficient for most of the patients or whether it must be
combined with decompression and stabilization, and, if
so, whether the surgery comes first followed by the irradi-
ation or in the opposite sequence. From the surgical stand
point of view surgery should definitely be before irradi-
ation if there is any probability that irradiation alone may
not be sufficient to treat the patient (Fig. 3). Surgery into
irradiated tissue has a significantly higher infection rate
(30%) and is more difficult to perform than done before
the irradiation [12, 15, 21, 34].
Surgical options
Indications for surgery are:
– Pain due to mechanical compression of the different pain-
producing structures or clear instability
– Symptomatic mechanical compression of neurostruc-
tures (neurological deficit)
– Rapidly progressing neurological deficit due to me-
chanical compression
– Unknown primary tumor with clearly defined metasta-
tic involvement of the spine
– Radioresistant tumor
– Neurological deterioration or increasing pain during or
after radiotherapy (should be avoided by a careful eval-
uation of the tumor potential before irradiation is de-
cided) [21]
Surgery generally is said to be indicated when the patient
is still in a general condition which safely allows surgery,
and if life expectancy is at least 6 months. The latter in-
creasingly depends on the kind of surgical procedures and
approaches which need to be chosen. This 6-month rule
may be overruled by the possibilities of less invasive sur-
gical procedures which allow a faster recuperation and
cause less surgical trauma.
Many of the criteria are used to make a surgical indi-
cation cannot be handled rigidly and must be weighted in
an interdisciplinary decision-making process. For exam-
ple, there is substantial debate over what is exactly an un-
stable spine, and consequently there may be patients who
are definitely overtreated with all the technical options
available today on the base of an obscure understanding
of instability. For example, applying the Denis classifica-
tion for traumatic thoracolumbar fractures may not be ap-
propriate as indication basis for surgical indications. There
are more appropriate concepts developed in oncological
surgery which should be applied to the metastatic spine
[13, 16, 32, 50, 51].
Fig. 3 Surgery ideally should be carried out before irradiation [1].
Irradiation which preceding surgery [2] has a significantly higher
complication rate [21]
S208
Fig. 4 Anterior surgery for metastatic spine disease. a Woman with
a kidney cancer, metastasing in the middle-thoracic spine. b Anterior
resection and stabilization by a metal-cement compound and subse-
quent irradiation. c A 62-year-old woman with a breast cancer me-
tastases into the C7 vertebra. d Resection, reconstruction with a tri-
calcium bone substitute block, and plating with consecutive irradia-
tion
In most instances the need to operate as radically as
possible is usually also an overkill since radicality in most
instances is not really possible, and most studies show that
the local surgery of the spine does not fundamentally change
the survival rate of these tumor patients, and very rarely
the operated local spinal tumor is the cause of the mortal-
ity [16, 24, 25, 33, 36, 54, 55, 56]. This, again, needs to be
kept in mind when deciding for surgery. The severity and
extent of surgery can be influenced by adjuvant measures
that may moderate the surgical intervention to an accept-
able degree. One such measure is the preoperative em-
bolization in vascularized spinal metastases or primary tu-
mors. This can reduce blood loss and consequently mor-
bidity and mortality drastically and facilitate the surgeon’s
work significantly. Kidney tumors, multiple myeloma, and
thyroid tumors should definitely be considered for preop-
erative embolization to reduce the blood loss.
Technically a spinal tumor located predominantly in
the vertebral body can be approached by anterior surgery
alone (Fig. 4) or in combination with a posterior proce-
dure (Fig. 2c–e), or it can be performed entirely through a
posterior approach leaving the patient with less morbidity
(Fig. 5). However, is must be recognized that endoscopic
anterior surgery for vertebral tumors, specifically in the
thoracic spine, where the surgeon can profit from the nat-
ural thoracic cavity in contrast to the lumbar spine, may
considerably diminish the morbidity of extensive anterior
surgery in the elderly. The goal is in any case to operate
on the patient in such a way that stay in the intensive care
unit can be avoided. Again, with modern retractor systems
and less invasive technology it is possible to perfect the
posterolateral approach to the anterior spine elements of
the thoracolumbar spine through a midline incision which
allows a laminectomy, a vertebral body resection, the an-
terior column reconstruction and posterior stabilization in
a single approach (Fig. 5) [41, 42]. In the middle and lower
cervical spine the anterior approach is most straightfor-
ward and yields little morbidity (Fig. 4c–d). In rare cases
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Fig. 5 Posterior surgery for metastatic spine disease. a A
73-year-old man with a metastases in L2 from a stomach
cancer. b, c Through a single median posterior incision
laminectomy, posterolateral resection of the vertebral body
through both pedicles, and posterior reconstruction and sta-
bilization with a short pedicular, angle stable system com-
bined with an anterior column reconstruction with metal-ce-
ment compound through the posterior approach. d, e Partial
resection and posterior stabilization of the upper cervical
spine involved by lung metastases followed by irradiation in
a 73-year-old man. Note the combination of a metal-cement
compound posteriorly instead of bony fusion
a combined procedure may be indicated to control the
pain mostly due to the instability (Fig. 5). At the occipito-
cervical junction a posterior resection and stabilization
combined with irradiation is generally sufficient as pallia-
tive measure. Some authors have recently enthusiastically
advocated minimally invasive technology to approach
certain lesions in particular in the vertebral body involve-
ment: Vertebroplasty or kyphoplasty as palliative technique
may increasingly gain significance in patients with high
morbidity index or elevated risk for open surgery [37, 38].
Reconstruction of the anterior column for stability rea-
sons as well as realignment of the spine is rarely carried
out with autologous bone because the average life ex-
pectancy does not justify it, and a possible postoperative
irradiation would damage the healing potential of an auto-
graft. Today this reconstruction is performed either with a
metal-cement compound as in building construction or
with the use of metal or ceramic spacers in combination
with cement, which may or may not be filled with bone
substitutes. Major allograft may be an alternative; how-
ever, the biological conditions for its integration are not
satisfactory, specifically in the case of adjuvant irradiation
and possible chemotherapy.
The stability of a diseased segment after tumor resection
can certainly be enhanced by a strong posterior instru-
mentation in combination with the anterior reconstruction
of the anterior column and is biomechanically superior to
a purely anterior reconstruction, even with anterior instru-
mentation [32]. The surgeon needs to keep in mind that
the major goal of the surgery is to put the patient in a con-
dition to be as soon as possible independently mobile
without any brace, which is an additional burden in those
severely ill and often rather cachectic patients with the po-
tential of pressure sores and unease with external fixation
devices.
Option of irradiation
The general principles that govern the outcome of treat-
ment of patients with malignant tumors of the spine are the
same as those for tumors at any other site. First, for pa-
tients to be considered cured all tumor cells at the primary,
regional, and distant sites must be inactivated or removed.
Second, the determinants of probability of success are the
anatomical site and size of the tumor and the histopatho-
logical type and grade of the tumor. Malignant lesions of
the spine are often not respected with secure margins be-
cause of the constraints imposed by the proximity of the
spinal cord and nerve roots, major vessels (especially along
the thoracic column), and organs (e.g., esophagus). An in-
tact spine is critical to an individual’s anatomical integrity.
Also, the role of radiation therapy for malignant tumors of
the spine is often severely limited by the necessity to in-
clude the spinal cord in the high-dose region because tu-
mor abuts on the dura and/or cord.
The patients in whom symptomatic spinal cord com-
pression develops often represent a debilitated and elderly
population with considerable surgical risks. Not all pa-
tients can safely undergo surgery either anteriorly or pos-
terolaterally or even in combination – although mostly not
necessary – with appropriate stabilization procedures. Nev-
ertheless, a considerable number of these are sufficiently
treated by irradiation, either because there are only mini-
mal neurological symptoms, or because an aggressive sur-
gical approach is deemed inappropriate at initial presenta-
tion [12]. The widespread use of MRI of the spine to de-
tect metastatic disease in patients with cancer, results in
the early diagnosis of epidural metastatic disease, which
often is irradiated since not really symptomatic. For many
reasons therefore more previously irradiated patients pre-
sent to the hospital with symptomatic spinal cord com-
pression. The number of major wound complications is high
in this population. Recent studies showed that spinal irra-
diation before surgical decompression for spinal cord com-
pression is associated with a significantly higher major
wound complication rate. In addition, preoperative spinal
irradiation might adversely affect the surgical outcome
[4], (Fig. 3).
Irradiation is an appropriate palliative pain treatment in
many patients; however, the indications need to be ratio-
nalized if we do not want to deal increasingly with cases
after irradiation who need surgery because irradiation did
not stop the tumor. Therefore the indications for irradiation
in most of the frequent bony and spinal metastases (breast,
prostate, lung, colon cancer, and multiple myeloma) are
[40]:
– Radiosensitive tumor (malignant lymphoma, myeloma,
small-cell lung cancer, seminoma, neuroblastoma, and
Ewing’s sarcoma).
– A lesion to the spine which does not compromise the
stability or the neurological function of the spinal cord
or its roots, but where the leading symptom is pain which
is difficult to control by medication alone.
– Mild compression of neurostructures without relevant
clinical neurological signs where it can be anticipated
that the irradiation will stop the further progression of
the tumor, or the patient’s life expectancy is less than
3–6 months.
– Paraplegia more than 24 h.
– Multiple level involvement of the spine where surgery
may be useless to control the metastatic disease. In this
case the irradiation is a desperate attempt to palliatively
influence the bony pain and to delay neurological com-
plication depending from the biological/histological char-
acteristics of the tumor.
– Disseminated disease with life expectancy less than
3–6 months.
– Tumor involvement for which recalcification of the ir-
radiated vertebra can be anticipated from the biological
behavior of the tumor more rapidly than a pathological
fracture in a weakened vertebra.
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– A general condition of the patient with a reduced resis-
tance rendering a surgical intervention impossible.
Patients who have a relevant symptomatic neurocompres-
sion or instability or a failed pain management after irra-
diation should no longer undergo irradiation, but a surgi-
cal option needs to be evaluated. This shared decision-
making process, once again should, be handled in a multi-
disciplinary team. Irradiation generally should not be per-
formed without a histological diagnosis, with very few
exceptions. In all those cases in which the primary tumor
is unknown or not sure, a biopsy is recommended of the
suspected vertebra either by a posterolateral percutaneous
approach or by the pedicle of the patient with a Yamshidi
needle of sufficient diameter (≥3 mm), usually in local
anesthesia and by image guidance to obtain a proper tis-
sue sample allowing a histological diagnosis. This can be
a simple hand-guided biopsy under image intensifier or a
computer-assisted one.
There is no radiotherapeutic regimen showing consis-
tent superiority in the treatment of spinal metastases, al-
though multiple treatment protocols have been carried out.
Usually 30y in 10 fractions (over 2 weeks) are applied.
Other commonly used regimens vary between 8 Gy in a
single fraction and 40 Gy in 20 fractions over 4 weeks [12].
Pharmacological options
Here we may consider chemotherapy, bisphosphonates, and
in some specific tumors hormonal therapy (breast, prostate,
thyroid cancer) and as a general medication steroids such as
dexamethasone. This is the most frequently used cortico-
steroid despite the fact that in the literature there is no valid
comparison of dexamethasone and methylprednisolone [35,
40]. Two dosing regimen are used: the high-dose dexameth-
asone regimen comprises an initial bolus of 100 mg with
subsequent dose of 96 mg/day. This regimen seems to have
only a historical value since significant side effects have
been associated with its use. It should be administered only
to patients with rapidly progressing neurological deficit.
The moderate-dose dexamethasone regimen starts with 10 mg
intravenous bolus and continues with 16 mg/day four times
daily [40, 52]. This dosage is well tolerated, and it is the
regimen of choice in symptomatic patients. No steroids are
proposed in nonparetic ambulatory patients.
Recently a new dimension in the treatment of bony
metastases has been advocated. Since it is well established
that bony metastases in general and of the spine in partic-
ular increase treatment costs and may significantly pro-
long hospital stay, new means of simple treatment of bony
metastases are being evaluated [24]. Bisphosphonates
have stood the test of time in the treatment of bony com-
plications because they stop the vicious circle of tumor
progression and pathological bone turnover. Under the ef-
fect of the tumor cells the balance between bone resorp-
tion and new bone formation is disturbed; tumor cells seed
in the bone under the attraction of growth factors [43].
There they deliberate mediators which stimulate both the
osteoclasts and osteoblasts, which start to turnover the
bone in an unphysiological way. Again, growth factors are
released which stimulate tumor cells for proliferation. The
vicious circle of pathological bone remodeling and tumor
progression starts. Subsequently bone quality and bone
density diminish. The stability of the bone strongly de-
creases. Bisphosphonates show a high affinity to bone and
are augmented mainly in locations with high bone turn-
over. They are therefore ideal medications to stop the vi-
cious circle of bone metastasing and damaging [42]. The
most successful medication is pamidronate (second-gen-
eration bisphosphonate) which is successful mostly in bony
metastases of breast cancer and in osteolysis in multiple
myeloma [4]. Zoledronic acid is one of the most recently
developed agents and is characterized by an imidazol
ring. In animal experiments the effect was 100–850 times
better than that with the older pamidronate [30, 39, 44].
The objective clinical success of the bisphosphonate
depends significantly on the reduction and delay of skele-
tal complications (SREs=pathological fracture, spinal cord
compression, need for irradiation or surgery for stabiliza-
tion) [19, 22]. It can be anticipated today that the bisphos-
phonates have an immediate antitumoral effect. Bisphos-
phonate treatment has the goal of diminishing the inci-
dence of bony complications, vertebral body fractures, pain,
and osteoporosis. The outcome should be determined by
the survival time – once a spinal metastasis is detected –
in an ambulatory, independent status, where pain is con-
trolled, and the patient is not hospitalized. The mean sur-
vival time is 14– 18 months depending obviously on the
patient’s condition before entering treatment for the spinal
problem. Wise et al. [56] report a mean survival time of
15.9 months after surgery for spinal metastasis, whereas
Weigel [55] reports a 13.1 months mean survival time with
11.1 months mean time at home after surgery. In our own
material of 67 fully documented cases between 1996 and
2001 the mean survival after surgery was 14.2 months (un-
published data). Tomita et al. [51] published recently sur-
vival times that were longer in cases in which wide or
marginal excision was made (38.2 months), with only 7%
local tumor recurrence, and the survival time in patients
treated with intralesional excision was 21.5 months and 31%
local tumor recurrence whereas only in patients with pallia-
tive surgery and stabilization the survival was 10.1 months
and the local tumor recurrence 28%. They based their sur-
gical decision making on a new prognostic scoring sys-
tem. Sundaresan et al. [49] reported a mean survival time
of 30 months in patients with surgery for solitary metas-
tases of the spine and with a survival of 5 years and more
in 18% of their cases. Mazel et al. [42] achieved a mean
survival rate of 16.7 months in 21 of 35 patients who died
and 38.2 months in 14 of 35 patients who were alive at
follow-up with a so-called radical excision of tumors of
thoracic and cervicothoracic metastases.
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These results also suggest a concept of differentiated
surgery with more radical options than just palliative sur-
gery. The neurological outcome is crucial and depends on
the initial neurological deficit before surgery. About one-
half of the paraparetic patients at the time of diagnosis re-
gain the ability to walk, but only fewer than 5% of pa-
tients, who are paraplegic regain ambulation [2]. Postop-
erative complications are frequent and are found in 15 –
30% of cases [55, 56].
Wai et al. [54] assessed prospectively the overall qual-
ity of life after surgical management of metastatic spine
disease, using a validated global health status quality-of-
life instrument (Edmonton Symptoms Assessment Scale).
They found the greatest improvement in the domain of
pain reduction, but there was also improvement in other
domains of quality of life. The clinical results of nonsur-
gical treatment for spinal metastases has been presented in
a prospective analysis of 101 patients who were treated
with radiation therapy and/or chemotherapy. Of these,
66% remained neurologically stable or improved after
treatment; 67% had pain relief, and 64% improved func-
tionally, which was more related to the general debility
than local tumor recurrence [33]. Unfortunately no
prospective study has compared nonsurgical and surgical
treatment of spinal metastases with clearly defined condi-
tions and parameters to allow a differentiated decision
about the best solution for the patient. It has also been
considered that such a study may be extremely difficult to
execute also for ethical reasons.
This leaves us with the necessity to assess every pa-
tient individually and to weigh the different elements in
shared decision making of an interdisciplinary team to-
gether with the patient. It is a complex algorithm tailored
to the patient’s individual problem and therapeutic options
available (Fig. 6). It cannot be emphasized enough that a
decision for a conservative treatment, specifically with ir-
radiation, should not be taken unless there is a clear un-
derstanding that a later surgical option is very improbable.
There is no doubt that preoperative irradiation has a sig-
nificantly negative effect on surgical outcome [21].
Fig. 6 Decision algorithm of the treatment tailored to the individ-
ual patient’s need and therapeutic option
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